Pharmacotherapy of borderline personality disorder

Robert M A Hirschfeld

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.

Original languageEnglish (US)
Pages (from-to)48-52
Number of pages5
JournalJournal of Clinical Psychiatry
Volume58
Issue numberSUPPL. 14
StatePublished - 1997

Fingerprint

Borderline Personality Disorder
Drug Therapy
Affective Symptoms
Ego
Antidepressive Agents
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Hirschfeld, R. M. A. (1997). Pharmacotherapy of borderline personality disorder. Journal of Clinical Psychiatry, 58(SUPPL. 14), 48-52.

Pharmacotherapy of borderline personality disorder. / Hirschfeld, Robert M A.

In: Journal of Clinical Psychiatry, Vol. 58, No. SUPPL. 14, 1997, p. 48-52.

Research output: Contribution to journalArticle

Hirschfeld, RMA 1997, 'Pharmacotherapy of borderline personality disorder', Journal of Clinical Psychiatry, vol. 58, no. SUPPL. 14, pp. 48-52.
Hirschfeld, Robert M A. / Pharmacotherapy of borderline personality disorder. In: Journal of Clinical Psychiatry. 1997 ; Vol. 58, No. SUPPL. 14. pp. 48-52.
@article{34309639a43445619d9e9277e3a7ab89,
title = "Pharmacotherapy of borderline personality disorder",
abstract = "Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.",
author = "Hirschfeld, {Robert M A}",
year = "1997",
language = "English (US)",
volume = "58",
pages = "48--52",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 14",

}

TY - JOUR

T1 - Pharmacotherapy of borderline personality disorder

AU - Hirschfeld, Robert M A

PY - 1997

Y1 - 1997

N2 - Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.

AB - Borderline personality disorder can be classified into four groups of symptoms: affective, impulsive, ego-interpersonal, and psychotic. Pharmacotherapy of borderline personality disorder should be directed at the severity of the symptoms in each of these groups, rather than by the presence or absence of the overall syndrome. This article reviews the pharmacotherapy of borderline personality disorder, with special emphasis on affective and impulsive symptoms. Overall, the MAOIs, the SSRIs, and the newer antidepressants (such as venlafaxine) provide the widest spectrum of effective treatment for the symptoms of borderline personality disorder.

UR - http://www.scopus.com/inward/record.url?scp=0031439545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031439545&partnerID=8YFLogxK

M3 - Article

VL - 58

SP - 48

EP - 52

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 14

ER -